Intermittent dosing prolongs tolerance to the antinociceptive effect of morphine microinjection into the

Michael M Morgan1, Bradley W Tierney, Susan L Ingram

  • 1Department of Psychology, Washington State University Vancouver, 98686, USA. morgan@vancouver.wsu.edu

Brain Research
|September 27, 2005
PubMed

Insights

Repeated morphine injections into the brain

Area of Science:

  • Neuroscience
  • Pharmacology
  • Pain Research

Background:

  • Tolerance to morphine's pain-relieving effects can develop with repeated use.
  • The ventrolateral periaqueductal gray (vPAG) is a key brain region for morphine's antinociceptive action.
  • Understanding tolerance mechanisms is crucial for effective pain management.

Purpose of the Study:

  • To investigate if the interval between morphine injections affects tolerance development and duration.
  • To compare tolerance magnitude and duration following different dosing schedules of direct vPAG morphine administration.

Main Methods:

  • Rats received microinjections of morphine or saline into the vPAG.
  • Two dosing schedules were used: once daily for 4 days or twice daily for 2 days.
  • Antinociceptive tolerance was assessed by measuring hot plate latency after a challenge morphine injection at later time points.

Main Results:

  • Morphine microinjection induced tolerance in both groups, irrespective of the inter-dose interval.
  • Tolerance persisted for 2 weeks in rats receiving daily injections, but not in those receiving twice-daily injections.
  • This suggests that longer intervals between direct brain morphine administration prolong tolerance duration.

Conclusions:

  • Direct morphine administration into the vPAG leads to tolerance.
  • The duration of morphine tolerance is dependent on the inter-dose interval, with longer intervals prolonging tolerance.
  • Associative learning mechanisms may contribute to prolonged tolerance even when morphine is administered directly into the brain's pain-modulating circuits.